Synthesis of Cbz-Protected Ketomethylene Dipeptide Isosteres
Part of the Methods in Molecular Medicine™ book series (MIMM, volume 23)
Ketomethylene peptide isosteres have been the focus of a variety of synthetic studies because of their potential as therapeutic agents in the treatment of medical conditions mediated by proteases (1, 2, 3). The dipeptide core units 1 are chemically characterized by a 1,4-disposition of the carbonyl groups (ketone and carboxylate) and have an alkyl group at C-2 that is a chiral center. Protecting groups at amino nitrogen (typically carbamate such as Cbz or Boc) and the carboxyl group (typically ester) are usually present to make processing easier but must be readily and independently removable to permit extension in either the N-terminal or C-terminal directions (Fig. 1).
KeywordsFlash Chromatography Normal Reaction Time Methyl Lactate Major Diastereomer Lithium Enolate
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
- 1.Sandler, M. and Smith, H. J. (1989) Design of Enzyme Inhibitors as Drugs, Oxford, Oxford, UK, pp. 573–649.Google Scholar
- 2.Rich, D. H. (1990) Peptidase Inhibitors, in Comprehensive Medicinal Chemistry (Sammes, P. G., ed.), Pergamon, Oxford, UK, pp. 391–441.Google Scholar
- 5.Casimir, J. R., Turetta, C, Ettouati, L., and Paris, J. (1995) First application of the Dakin-West reaction to Fmoc chemistry: syntyhesis of the ketomethylene tripeptide F-moc-Na-Asp(tBu)-(R(S)Tyr(tBu)ψPCO-CH2)Gly-OH. Tetrahedron Lett. 36, 4797–4800.Google Scholar
- 10.Vara Prasad, J. V. N., and Rich, D. H. (1991) Synthesis of hydroxyethylene dipeptide isosteres that mimic a cyclic amino acid at the PI′ subsite. Tetrahedron Lett. 32, 5857–5860.Google Scholar
- 13.Gonzalez-Muniz, R., Garcia-Lopez, M. T., Gomez-Monterrey, I., Herranz, R., Jimeno, M. L., Suarez-Gea, M. L., Johansen, N. L., Madsen, K., Thøgersen, H., and Suzdak, P. (1995) Ketomethylene and (Cyanomethylene)amino pseudo-peptide analogues of the C-terminal hexapeptide of neurotensin. J. Med. Chem. 38, 1015–1021.CrossRefGoogle Scholar
- 16.Lygo, B. (1992) Use of an alanine derived β-ketosulfone in the synthesis of peptide isosteres. Synlett 793–795.Google Scholar
- 25.Kempf, D. J., Codacovi, L., Wang, X. C, Kohlbrenner, W. E., Wideburg, N. E., Saldiver, A., Vasavannonda, S., Marsh, K. C, Bryant, P., Sham, H. L., Green, B. E., Betebenner, D. A., Erickson, J., and Norbeck, D. W. (1993) Symmetry-based inhibitors of HIV protease, structure-activity studies of acylated 2,4-diamino-1,5-diphenyl—3-hydroxypentane and 2,5-diamino-1,6-diphenylhexane-3,4-diol. J. Med. Chem. 36, 320–330.CrossRefGoogle Scholar
- 26.Jendralla, H., Henning, R., Seuring, B., Herchen, J., Kulitzscher, B., and Wunner, J. (1993) Short and efficient large scale synthesis of (R)-2-benzylsuccinic acid 4-[4-(BOC-amino)-1-piperidide] monoamide: N-terminal component of renin inhibitors by asymmetric hydrogenation. Synlett 155–157.Google Scholar
- 27.Thompson, W. J., Ghosh, A. K., Holloway, M. K., Lee, H. Y., Munson, P. M., Schwering, J. E., Wai, J., Darke, P. L., Zugay, J., Emini, E. A., Schlief, W. A., Huff, J. R., and Anderson, P. A. (1993) 3′-Tetrahydrofuranylglycine as a novel, unnatural amino acid surrogate for asparagine in the design of inhibitors of the HIV protease. J. Am. Chem. Soc, 115, 801–803.CrossRefGoogle Scholar
- 28.Beckett, R. P., Brown, P. D., Crimmin, M. J., and Galloway, W. A. (1993) Paper No. 147, Medicinal Chemistry, 204th National Meeting of the American Chemical Society, Denver, CO.Google Scholar
© Humana Press Inc., Totowa, NJ 1999